These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 1889863)

  • 1. Antibiotic usage for initial empirical treatment of infections in hospitalized patients in West Germany.
    Knothe H
    Infection; 1991; 19(3):127-30. PubMed ID: 1889863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group.
    Barie PS; Vogel SB; Dellinger EP; Rotstein OD; Solomkin JS; Yang JY; Baumgartner TF
    Arch Surg; 1997 Dec; 132(12):1294-302. PubMed ID: 9403533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections.
    Garbino J; Villiger P; Caviezel A; Matulionyte R; Uckay I; Morel P; Lew D
    Infection; 2007 Jun; 35(3):161-6. PubMed ID: 17565457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imipenem-cilastatin vs. tobramycin and metronidazole for appendicitis-related infections.
    Uhari M; Seppänen J; Heikkinen E
    Pediatr Infect Dis J; 1992 Jun; 11(6):445-50. PubMed ID: 1608680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of nosocomial infections in children undergoing antimicrobial chemotherapy.
    Bonatti H; Guggenbichler JP; Hager J
    Infection; 1990; 18(5):302-6. PubMed ID: 2276826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis.
    Jaccard C; Troillet N; Harbarth S; Zanetti G; Aymon D; Schneider R; Chiolero R; Ricou B; Romand J; Huber O; Ambrosetti P; Praz G; Lew D; Bille J; Glauser MP; Cometta A
    Antimicrob Agents Chemother; 1998 Nov; 42(11):2966-72. PubMed ID: 9797234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections.
    Cakmakci M; Stern A; Schilling J; Christen D; Roggo A; Geroulanos S
    Drugs Exp Clin Res; 1993; 19(5):223-7. PubMed ID: 8174495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of intra-abdominal infections using imipenem/cilastatin.
    Leaper D; Thomas W; Kennedy R; Leow C; Avery D
    Chemioterapia; 1987 Jun; 6(2 Suppl):467-8. PubMed ID: 3334603
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antibiotic therapy in severe infections].
    Vogel F
    Anasth Intensivther Notfallmed; 1983 Oct; 18(5):250-7. PubMed ID: 6660441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calculated initial chemotherapy in mechanically-ventilated postoperative patients with peritonitis, sepsis and pneumonia].
    Hünefeld G; Weissbrodt H; Aebert H; Bunzendahl H
    Infection; 1986; 14 Suppl 2():S164-70. PubMed ID: 3759251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic antibiotic treatment of nosocomial pneumonia.
    Unertl KE; Lenhart FP; Forst H; Peter K
    Intensive Care Med; 1992; 18 Suppl 1():S28-34. PubMed ID: 1640030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial therapy of bacterial sepsis in the newborn infant.
    Starr SE
    J Pediatr; 1985 Jun; 106(6):1043-8. PubMed ID: 3889254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipenem/cilastatin versus aminoglycoside plus amoxicillin plus clindamycin in the treatment of serious postoperative infections.
    Christen D; Buchmann P; Geroulanos S
    Scand J Infect Dis Suppl; 1987; 52():11-4. PubMed ID: 3331039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoglycosides in gynecologic infections.
    Ledger WJ
    Am J Med; 1986 Jun; 80(6B):216-21. PubMed ID: 3728531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monotherapy in serious hospital-acquired infections: a clinical trial of ceftazidime versus imipenem/cilastatin. European Study Group.
    Norrby SR; Finch RG; Glauser M
    J Antimicrob Chemother; 1993 Jun; 31(6):927-37. PubMed ID: 8360130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal sepsis in Turkey: the comparison between penicillin plus aminoglycoside and ampicillin plus third-generation cephalosporin chemotherapies.
    Gökalp AS; Oğuz A; Gültekin A; Içağasioğlu D
    Mater Med Pol; 1991; 23(3):226-8. PubMed ID: 1842721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approach to therapy of respiratory infections in the critical care setting.
    Pennington JE
    Semin Respir Infect; 1990 Sep; 5(3):226-32. PubMed ID: 2255806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High variability among Emergency Departments in 3rd-generation cephalosporins and fluoroquinolones use for community-acquired pneumonia.
    Batard E; Lecadet N; Goffinet N; Hardouin JB; ; Lepelletier D; Potel G; Montassier E
    Infection; 2015 Dec; 43(6):681-9. PubMed ID: 25998004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospitalized patients with community-acquired pneumonia in Hong Kong: a randomized study comparing imipenem/cilastatin and ceftazidime.
    Ho A; Leung R; Lai CK; Chan TH; Chan CH
    Respiration; 1997; 64(3):224-8. PubMed ID: 9154675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.